Protirelin
Spécifications
24305-27-9Numéro CAS
246-143-4Numéro CE
(2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamideNom IUPAC
C16H22N6O4Formule chimique
362.38 g/molMasse molaire
protirelin; 24305-27-9; Thyroliberin; Lopremone; Synthetic TRH; Rifathyroin; Thypinone; Thyrotropin-releasing factor; TSH-releasing factor; Protireline; Thyrotropic-releasing factor; 5-Oxo-L-prolyl-L-histidyl-L-prolinamide; ABBOTT-38579; Protirelinum; THYREL TRH; Synthetic tsh-releasing factor; Relefact TRH; Abbott 38579; Protirelin, synthetic; Protirelina; DTXSID0023533; 5-oxo-pro-his-pro-nh2; L-Pyroglutamyl-L-histidyl-L-prolineamide; Protireline [INN-French]; Protirelinum [INN-Latin]; FDA 1725; L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-; Protirelina [INN-Spanish]; CCRIS 2593; Ro 8-6270/9; Relefact TRH (TN); Protirelin [USAN:INN:BAN:JAN]; PROTIRELIN [INN]; PROTIRELIN [JAN]; EINECS 246-143-4; PROTIRELIN [USAN]; (2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide; PROTIRELIN [VANDF]; 5Y5F15120W; NSC-760113; PROTIRELIN [MART.]; PROTIRELIN [WHO-DD]; L-Pyroglutamyl-L-histidinyl-L-prolinamide; DTXCID403533; PROTIRELIN [ORANGE BOOK]; CHEBI:35940; PROTIRELIN [EP MONOGRAPH]; A-38579; NSC 760113; Protireline (INN-French); Protirelinum (INN-Latin); Protirelina (INN-Spanish); PROTIRELIN (MART.); PROTIRELIN (EP MONOGRAPH); (2S)-N-[(2S)-1-[(2S)-2-aminocarbonylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]-5-oxidanylidene-pyrrolidine-2-carboxamide; pyroglutamyl-histidyl-prolylamide; Thyrotropin Releasing Factor; Trh-cambridge; TRH, Relefact; (2S)-N-((2S)-1-((2S)-2-aminocarbonylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl)-5-oxidanylidene-pyrrolidine-2-carboxamide; (2S)-N-((2S)-1-((2S)-2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)-5-oxopyrrolidine-2-carboxamide; Abbott38579; Thyroliberin TRH Merck; RefChem:870039; V04CJ02; Thyrotropin Releasing Hormone TRH; pyroGlu-His-Pro-NH2 (or 5-oxo-L-prolyl-L-histidyl-L-prolinamide); 246-143-4; Protirelin Acetate; L-Pyroglutamyl-L-histidyl-L-prolinamide; TRH; 117217-40-0; HOLO-TRANSFERRIN; C16H22N6O4; MFCD00038640; NCGC00160616-01; (S)-N-((S)-1-((S)-2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)-5-oxopyrrolidine-2-carboxamide; Synthetic TRF; Relefact-TRH; TRF; Thyrefact; Protirelin?; trh-sr; Protirelin CRS; UNII-5Y5F15120W; Human Transferrin; Stimu-TSH; Thyrotropin-releasing factor (pig); 24305-27-9 (free base); PR 546; PR-546; Synthetic thyrotropin-releasing factor; D-His-Protirelin CRS; PyroGlu-His-prolinamide; TSH-RF; TRH [MI]; CHEMBL1472; SCHEMBL33419; [3H]-TRH; GTPL2139; GTPL3836; orb1685534; SCHEMBL2182035; Siderophilin;partially saturated; pyroglutamyl-histidyl-prolinamide; Protirelin (JP18/USAN/INN); SCHEMBL19825647; [3H]TRH (human, mouse, rat); HY-P0002; Synthetic thyrotopin releasing factor; Tox21_111939; BDBM50072394; EBC-26800; s4680; AKOS015994636; AKOS040759052; CCG-268193; DB09421; FP33965; HS-2023; (2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide; DA-64226; L-Pyroglutamyl-L-histidyl-L-proline amide; CAS-24305-27-9; NS00006015; T6956; C03958; C74244; D00176; Prolinamide, 5-oxo-L-prolyl-L-histidyl-, L-; L-PYROGLUTAMYL-L-HISTIDYL-L-PROLINE-AMIDE; (Pyro)-L-glutamic acid-L-histidine-L-proline-NH2; EN300-27034140; Q24726011; Prolinamide, 1-[N-(5-oxo-L-prolyl)-L-histidyl]-, L-; (2S)-1-[(2S)-3-(1H-imidazol-5-yl)-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}propanoyl]pyrrolidine-2-carboxamide; (2S)-N-[(1S)-2-[(2S)-2-carbamoylpyrrolidin-1-yl]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide; (2S)-N-[(1S)-2-[(2S)-2-carbamoylpyrrolidino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide; 1-(3-(1H-Imidazol-5-yl)-2-([(5-oxo-2-pyrrolidinyl)carbonyl]amino)propanoyl)-2-pyrrolidinecarboxamide #; 1-[3-(1H-4-imidazolyl)-2-(5-oxotetrahydro-1H-2-pyrrolylcarboxamido)propanoyl]tetrahydro-1H-2-pyrrolecarboxamide; 2-Pyrrolidinecarboxamide, N-[1-[(2-carbamoyl-1-pyrrolidinyl)carbonyl]-2-imidazol-4-ylethyl]-5-oxo-,; 2-Pyrrolidinecarboxamide, N-[1-[(2-Carbamoyl-1-pyrrolidinyl)carbonyl]-2-imidazol-4-ylethyl]-5-oxo-, (S,S,S)-Synonymes
